GlassScriptPhysician profile
Frank Sarfo
NPI 1760047765
$2,706.55
in general payments reported to CMS, 2019-2025
26 companies · $1,163 in 2025
The $1,163 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.91 · 2022: $245 · 2023: $543 · 2024: $663 · 2025: $1,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,014 · Long Term Medical Supply Or Device Loan: $255 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,014.12 |
| Long Term Medical Supply Or Device Loan | $255.11 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $325.46 | 2023-2024 | |
| Integra Lifesciences Corporation | $274.11 | 2024-2025 | Micromatrix, Integra, Primatrix |
| Abbvie INC. | $245.22 | 2023-2025 | Botox |
| Sumitomo Pharma America, INC. | $215.76 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $199.38 | 2022-2024 | Ams 700, Moses 550 Dfl |
| Janssen Biotech, INC. | $182.71 | 2025 | Erleada |
| Olympus America INC. | $153.17 | 2022-2025 | Itind System |
| Baxter Healthcare | $120.00 | 2024 | Floseal, Tisseel |
| Myriad Genetic Laboratories, INC. | $109.14 | 2024-2025 | Prolaris |
| Antares Pharma, INC. | $105.56 | 2024-2025 | Xyosted |
| Endo Pharmaceuticals INC. | $96.00 | 2023 | Xiaflex |
| Allergan, INC. | $91.91 | 2021 | |
| Medtronic, INC. | $71.99 | 2025 | Interstim |
| Teleflex LLC | $65.04 | 2024-2025 | Barrigel, Urolift |
| Endo USA, INC. | $60.49 | 2024-2025 | Xiaflex |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $57.78 | 2025 | Provenge |
| Pfizer INC. | $54.71 | 2025 | |
| Laborie Medical Technologies Corp. | $53.73 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Astellas Pharma US INC | $53.56 | 2025 | Xtandi |
| Novartis Pharmaceuticals Corporation | $28.21 | 2025 | |
| Progenics Pharmaceuticals, INC. | $26.97 | 2024 | |
| Procept Biorobotics Corporation | $26.50 | 2025 | |
| Coloplast Corp | $25.76 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.03 | 2025 | |
| Azurity Pharmaceuticals, INC. | $22.19 | 2025 | Azmiro |
| Immunitybio, INC. | $18.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Sarfo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.